ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
0 |
00:07 |
00:07 |
ASX - By Stock
|
373
|
107K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
5 |
00:05 |
00:05 |
ASX - By Stock
|
630
|
290K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
9 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
100
|
27K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
373
|
107K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
4 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
100
|
27K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
373
|
107K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
5 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
630
|
290K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
3 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
373
|
107K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
6 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
8 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
spnc
|
100 |
27K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
27K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: TLX101-CDx (Pixclara) Granted FDA Fast Track Designation
|
|
spnc
|
8 |
4.1K |
14 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
8
|
4.1K
|
14
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
3 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
630
|
290K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
373
|
107K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
6 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
373
|
107K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
373
|
107K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
spnc
|
373 |
107K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
373
|
107K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
4 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
630
|
290K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
630
|
290K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of ARTMS
|
|
spnc
|
2 |
749 |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
2
|
749
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of ARTMS
|
|
spnc
|
2 |
749 |
7 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
2
|
749
|
7
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
630
|
290K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of IsoTherapeutics
|
|
spnc
|
4 |
2.1K |
5 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4
|
2.1K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Acquisition of IsoTherapeutics
|
|
spnc
|
4 |
2.1K |
5 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
4
|
2.1K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
5 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
630
|
290K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
2 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
630
|
290K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
5 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
630
|
290K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix General Meeting Presentation
|
|
spnc
|
26 |
7.9K |
4 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
26
|
7.9K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix General Meeting Presentation
|
|
spnc
|
26 |
7.9K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
26
|
7.9K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix General Meeting Presentation
|
|
spnc
|
26 |
7.9K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
26
|
7.9K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix General Meeting Presentation
|
|
spnc
|
26 |
7.9K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
26
|
7.9K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix General Meeting Presentation
|
|
spnc
|
26 |
7.9K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
26
|
7.9K
|
0
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
spnc
|
24 |
14K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
24
|
14K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
630
|
290K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
'The most exciting new technology that has the most potential to be transformative to medicine' (Novartis CEO)
|
|
spnc
|
24 |
14K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
24
|
14K
|
2
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
spnc
|
630 |
290K |
3 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
630
|
290K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
spnc
|
1.5K |
556K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.5K
|
556K
|
2
|
|